Punit Dhillon - Aug 26, 2024 Form 4 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Chief Executive Officer, Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Aug 26, 2024
Transactions value $
$0
Form type
4
Date filed
8/27/2024, 05:20 PM
Previous filing
Mar 1, 2024
Next filing
Oct 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SKYE Common Stock Other +15.7K +3.96% 413K Aug 26, 2024 Direct F1
holding SKYE Common Stock 9.34K Aug 26, 2024 Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received by reporting person in connection with one of Issuer's shareholders pro rata distribution of common stock of Issuer to its shareholders.
F2 Shares held by a family trust of which the reporting person is the trustee.